| __timestamp | Amphastar Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 5280000 |
| Thursday, January 1, 2015 | 37065000 | 7148000 |
| Friday, January 1, 2016 | 41199000 | 19594000 |
| Sunday, January 1, 2017 | 43415000 | 22894000 |
| Monday, January 1, 2018 | 57564000 | 50337000 |
| Tuesday, January 1, 2019 | 68853000 | 109450000 |
| Wednesday, January 1, 2020 | 67229000 | 90450000 |
| Friday, January 1, 2021 | 60932000 | 104128000 |
| Saturday, January 1, 2022 | 74771000 | 108630000 |
| Sunday, January 1, 2023 | 73741000 | 134951000 |
In pursuit of knowledge
In the ever-evolving world of pharmaceuticals, innovation is the lifeblood that drives progress. Over the past decade, Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) spending.
From 2014 to 2023, Rhythm Pharmaceuticals has consistently increased its R&D investment, culminating in a 2,456% rise by 2023. This aggressive strategy underscores their commitment to pioneering new treatments. In contrast, Amphastar Pharmaceuticals has adopted a more measured approach, with a 160% increase over the same period.
By 2023, Rhythm Pharmaceuticals' R&D expenses were nearly double those of Amphastar, highlighting their focus on innovation. This strategic divergence reflects broader industry trends, where companies must balance immediate profitability with long-term growth through innovation.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Biogen Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Rhythm Pharmaceuticals, Inc. vs Veracyte, Inc.
Rhythm Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation
Rhythm Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Research and Development Investment: Rhythm Pharmaceuticals, Inc. vs Evotec SE
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.